William Blair upgraded 10x Genomics Inc. TXG stock, citing it as the best-in-class technology and is well-positioned to ...

Andreas Pfenning discusses the techniques being developed and used to study neuronal heterogeneity and the therapeutic potential of his work.

引言在血液系统恶性肿瘤的治疗中，嵌合抗原受体T细胞 (Chimeric Antigen Receptor T cell, CAR-T) ...